Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

17.56
Delayed Data
As of Apr 24
 -0.29 / -1.62%
Today’s Change
10.85
Today|||52-Week Range
33.82
-7.34%
Year-to-Date

Today’s Trading

Previous close17.85
Today’s open17.81
Day’s range17.49 - 18.39
Volume11,732,968
Average volume (3 months)17,000,322
Market cap$19.5B
Data as of 4:01pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)-23,426.50%
Earnings growth (this year)-39.00%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+2.60%
P/E ratioNM
Price/Sales0.85
Price/Book1.42

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd+0.15+0.09%
TYMETyme Technologies In...-0.04-1.84%
OASMOasmia Pharmaceutica...-0.23-12.09%
Data as of 4:00pm ET, 04/24/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)$0.71
Annual revenue (last year)$22.5B
Annual profit (last year)-$16.4B
Net profit margin-72.66%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Kåre Schultz
Executive Vice President-
Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts